Abstract
Background and Aims: ADAPTABLE is the first PCOR trial in US, comparing the effectiveness of two aspirin doses for secondary prevention of atherosclerotic disease. Novel features include patients’ representation as research partners, leveraging of electronic health records, participation via internet and low cost. Direct patient engagement can improve research impact and provide access to minority populations, often less represented in clinical research. We aim to analyze patient's data from Montefiore Hospital in Bronx, NY, serving a community of socioeconomically disadvantaged minorities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
